Related Experiment Video
Updated: Apr 18, 2026

Surgical Management of Meatal Stenosis with Meatoplasty
Published on: November 30, 2010
Withholding postoperative antibiotics in pediatric circumcision: A randomized non-inferiority trial in a tropical
Armean Saema1, Chinnakhet Ketsuwan2
1Department of Surgery, Pattani Hospital, Pattani, Thailand.
Insights
Withholding routine antibiotics for pediatric circumcision is as safe as giving them, with no increased risk of surgical site infections (SSIs). This antibiotic-sparing approach aligns with antimicrobial stewardship principles.
Area of Science:
- Pediatric Surgery
- Infectious Disease Prevention
- Clinical Trials
Background:
- Routine antibiotic use in pediatric circumcision lacks strong evidence for elective procedures.
- This study addresses the common practice of antibiotic prescription in clean elective circumcisions.
- Investigates the efficacy of withholding antibiotics versus standard administration.
Purpose of the Study:
- To determine if withholding routine antibiotics is non-inferior to standard postoperative administration for preventing surgical site infections (SSIs).
- To evaluate the safety and efficacy of an antibiotic-sparing strategy in pediatric circumcision.
- To support antimicrobial stewardship principles in pediatric surgical care.
Main Methods:
- A single-center, randomized, non-inferiority trial involving healthy boys aged 5-15 years undergoing elective circumcision.
- Participants were randomized to receive either standard postoperative oral antibiotics or no antibiotics.
- The primary outcome was SSI within 21 days, with non-inferiority defined by a specific confidence interval for the risk difference.
Main Results:
- 155 patients completed the per-protocol analysis (80 antibiotics, 75 no antibiotics).
- Surgical site infections (SSIs) occurred in 1.3% of patients in both the antibiotic and no-antibiotic groups.
- The risk difference of 0.0% met the non-inferiority criterion, with no serious adverse events reported.
Conclusions:
- Withholding routine antibiotics in healthy children undergoing elective circumcision is non-inferior to standard postoperative use regarding infection risk.
- This approach supports antibiotic-sparing strategies and aligns with antimicrobial stewardship.
- The findings suggest a potential reduction in unnecessary antibiotic exposure in pediatric circumcision.
Background:
Routine antibiotic prescription is commonly practiced in pediatric circumcision, despite limited evidence supporting its benefit in clean elective procedures. This study aimed to determine whether withholding routine antibiotics is non-inferior to standard postoperative administration in preventing surgical site infections (SSIs) in healthy children undergoing elective circumcision.
Methods:
This single-center, randomized, non-inferiority trial enrolled boys aged 5-15 years scheduled for elective circumcision. Participants were allocated to receive either standard postoperative oral antibiotics or no antibiotics. The primary outcome was an SSI within 21 days, assessed by blinded evaluators, with non-inferiority defined as an upper limit of the 95% confidence interval (CI) for the risk difference of <5%.
Results:
Of 175 screened patients, 155 were included in the per-protocol analysis (80 antibiotics; 75 no antibiotics). SSIs occurred in one patient in each group (1.3% vs. 1.3%), yielding a risk difference of 0.0% (95% CI -3.8% to 3.8%), which met the non-inferiority criterion. Secondary outcomes were comparable between the groups, and no serious adverse events were observed.
Conclusion:
Withholding antibiotics in healthy children undergoing elective circumcision is non-inferior to routine postoperative use with respect to infection risk and supports an antibiotic-sparing approach consistent with antimicrobial stewardship principles.
Trial Registration:
Thai Clinical Trials Registry (TCTR20250818001).
More Related Videos
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmacokinetics in Pediatric Patients: Drug Excretion

